Mid-Parental Height Calculator- Free Online Tool

Mid-Parental Height Calculator: Predict Your Child’s Adult Height Using the Tanner Method

Every parent wonders how tall their child will eventually become. While no method can predict adult height with absolute certainty, the mid-parental height (MPH) calculation remains one of the most widely used and clinically validated tools for estimating a child’s genetic height potential. First described by Tanner, Goldstein, and Whitehouse in 1970, this method uses the biological parents’ heights to calculate a target height range that reflects the child’s inherited growth potential. Pediatric endocrinologists, primary care physicians, and growth specialists worldwide rely on the mid-parental height formula as a foundational component of pediatric growth assessment.

The mid-parental height calculator provided on this page implements the standard Tanner method, allowing you to input both parents’ heights in either centimeters or feet and inches. It instantly calculates the child’s predicted adult height along with the expected target height range, giving families and healthcare providers a quick, evidence-based reference point for evaluating whether a child’s growth trajectory aligns with their genetic potential.

Understanding Mid-Parental Height and Genetic Growth Potential

Mid-parental height is a calculated estimate of a child’s expected adult stature based on the biological parents’ heights. The concept rests on the well-established principle that height is a highly heritable trait, with genetic factors accounting for approximately 60% to 80% of the variation in adult height across populations. The remaining 20% to 40% is influenced by environmental factors including nutrition, overall health, hormonal function, and socioeconomic conditions during childhood and adolescence.

The Tanner method, introduced in a landmark 1970 publication in Archives of Disease in Childhood, uses a simple sex adjustment to account for the average 13-centimeter difference between adult male and female heights at the same percentile. By adding 13 cm to the mother’s height when calculating for boys (or subtracting 13 cm from the father’s height when calculating for girls), the formula effectively converts both parents’ heights to the same sex-adjusted scale before averaging. This elegant approach has remained the standard clinical practice for over five decades, endorsed by organizations such as the Growth Hormone Research Society, the Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology.

Height inheritance follows a polygenic pattern, meaning thousands of genetic variants work together to influence final adult stature. Major genes affecting growth include those involved in the growth hormone and insulin-like growth factor 1 (IGF-1) signaling pathway, bone morphogenetic proteins, and growth plate regulation. Because height is influenced by so many genetic loci, it tends to follow a normal (bell-curve) distribution in the population, and children’s heights tend to regress toward the population mean relative to their parents’ heights.

How to Use the Mid-Parental Height Calculator

Using this calculator is straightforward. You need three pieces of information: the biological father’s height, the biological mother’s height, and the child’s sex. Enter the father’s height and mother’s height using either centimeters or the feet-and-inches system. Select whether you are calculating for a boy or a girl. The calculator will instantly display the predicted mid-parental height (target height), along with the target height range representing the 3rd to 97th percentiles.

For the most accurate results, use measured heights rather than self-reported heights. Research published in the International Journal of Pediatric Endocrinology has demonstrated that parents frequently overestimate their own heights, with fathers overreporting by an average of 1.7 cm and mothers by approximately 0.5 cm. These inaccuracies can shift the calculated mid-parental height and potentially lead to inappropriate clinical decisions. If measured heights are unavailable, be aware that the calculated target height may be slightly higher than the true genetic potential.

The results should be interpreted within the context of the child’s overall growth pattern, including their current height percentile, growth velocity, bone age, and pubertal status. A child whose projected adult height falls within the calculated target height range is generally considered to have growth consistent with their genetic potential. A projected height significantly below the target range may warrant further evaluation by a healthcare provider.

The Science Behind Height Inheritance

Height is one of the most extensively studied human traits, with genome-wide association studies (GWAS) identifying over 12,000 genetic variants associated with adult stature. These variants collectively explain a substantial proportion of height heritability, though no single gene has a dominant effect. The polygenic nature of height means that each parent contributes roughly half of the genetic information influencing their child’s final stature, making the average of both parents’ heights a reasonable starting point for prediction.

The concept of regression to the mean plays an important role in height prediction. First described by Sir Francis Galton in the 1880s, regression to the mean indicates that very tall parents tend to have children who are somewhat shorter than the parents’ average, while very short parents tend to have children who are somewhat taller than the parents’ average. This statistical phenomenon occurs because the extreme combination of height-increasing (or height-decreasing) genetic variants in the parents is unlikely to be fully replicated in any single child. Population-based studies have estimated the heritability of height at 0.75 to 0.78 when measured in centimeters, and 0.55 to 0.60 when expressed in standard deviation scores, reflecting this regression effect.

Research from the International Pediatrics Growth Research Center at the University of Gothenburg, using population data of over 2,400 individuals, proposed a refined linear regression model: target height (boys) = 45.99 + 0.78 times mid-parental height, and target height (girls) = 37.85 + 0.75 times mid-parental height, with a 95% predicted interval of approximately plus or minus 10 cm. This model accounts for regression to the mean and may provide more accurate predictions than the standard Tanner method, particularly for children of very short or very tall parents.

Clinical Applications of Mid-Parental Height

In clinical practice, the mid-parental height calculation serves several important purposes. It is a foundational component of the initial evaluation of any child presenting with concerns about growth. When a child’s projected adult height (based on current height percentile and bone age) deviates significantly from the calculated target height, this discrepancy signals the need for further investigation into potential underlying causes of abnormal growth.

Pediatric endocrinologists routinely use mid-parental height in the differential diagnosis of short stature. Familial short stature, where a child is short but growing at a normal rate with short parents, is distinguished from pathological short stature partly by comparing the child’s growth trajectory to the parental target height range. A child whose height falls within the parental target range is more likely to have familial short stature, while a child whose height falls significantly below this range may have an underlying medical condition requiring treatment.

Mid-parental height also serves as a benchmark for evaluating the effectiveness of growth-promoting therapies, including growth hormone treatment. Clinical trials for conditions such as idiopathic short stature (ISS), growth hormone deficiency, Turner syndrome, and small for gestational age use the difference between achieved adult height and mid-parental height as an important outcome measure. The Growth Hormone Research Society and the Pediatric Endocrine Society have both recommended incorporating mid-parental height into standard growth assessment protocols.

Factors That Influence Final Adult Height Beyond Genetics

While genetics establishes the framework for growth potential, numerous environmental and physiological factors determine whether a child reaches their full genetic height potential. Nutrition is the single most powerful environmental modifier of growth. Chronic malnutrition, micronutrient deficiencies (particularly zinc, iron, vitamin D, and calcium), and severe caloric restriction during critical growth periods can significantly impair linear growth. Conversely, adequate nutrition in populations that were previously nutritionally deprived is the primary driver of the secular trend in increasing average height observed worldwide over the past century.

Hormonal factors play a critical role in growth regulation. Growth hormone (GH), secreted by the anterior pituitary gland, stimulates the production of insulin-like growth factor 1 (IGF-1) in the liver and directly at the growth plates. Thyroid hormones are essential for normal growth plate function and skeletal maturation. Sex steroids (estrogen and testosterone) drive the pubertal growth spurt but also ultimately cause growth plate fusion, ending linear growth. Conditions that disrupt any of these hormonal axes can impair growth and prevent a child from reaching their genetic height potential.

Chronic diseases such as celiac disease, inflammatory bowel disease, chronic kidney disease, congenital heart disease, and chronic respiratory conditions can all impair growth through mechanisms including chronic inflammation, malabsorption, metabolic derangements, and increased energy expenditure. Psychosocial factors, including severe emotional deprivation and chronic stress, can suppress growth hormone secretion through a mechanism known as psychosocial short stature. Sleep quality and duration also matter, as growth hormone is primarily secreted in pulsatile fashion during deep sleep stages.

Limitations of the Mid-Parental Height Formula

Despite its widespread clinical use, the Tanner mid-parental height method has several recognized limitations that users should understand. First, the formula assumes a constant 13-centimeter difference between male and female heights at all percentiles. However, analysis of CDC growth charts reveals that this difference actually varies by percentile, ranging from approximately 12.4 cm at the 3rd percentile to 14.0 cm at the 97th percentile. This means the standard formula may slightly overestimate target height for children of shorter parents and underestimate it for children of taller parents.

Second, the Tanner method does not account for regression to the mean. As discussed earlier, children of very tall or very short parents tend to be somewhat closer to the population average than their parents. By simply averaging the parents’ sex-adjusted heights, the formula may overestimate the target height for children of tall parents and underestimate it for children of short parents. Refined models that incorporate regression to the mean, such as the Gothenburg formula, may provide more accurate predictions in these extreme cases.

Third, the formula does not correct for the age of the parents. Adults lose height as they age due to spinal disc compression, vertebral body changes, and postural alterations. Parents who are measured in their 40s, 50s, or older may be several centimeters shorter than their peak adult height. Without correcting for this age-related height loss, the calculated target height will be lower than the child’s true genetic potential. A 2024 study by Rennert and colleagues demonstrated that correcting for parental age significantly improved the accuracy of target height predictions.

Finally, the formula requires the heights of both biological parents, which may not be available in cases of adoption, donor conception, single-parent families where one parent is unknown, or situations where one parent has a medical condition affecting their height (such as skeletal dysplasia or spinal surgery). In these circumstances, alternative methods of growth assessment must be used.

Validation Across Diverse Populations

The original Tanner mid-parental height formula was developed using data from predominantly white European populations in the United Kingdom. Since then, the formula has been studied and applied across diverse populations worldwide, with varying degrees of accuracy. Population-based studies from Europe, North America, East Asia, South Asia, the Middle East, and Latin America have generally confirmed that mid-parental height provides a reasonable estimate of genetic height potential, though the specific sex adjustment factor and target height range may vary slightly across populations.

Some studies have found that the standard 13 cm sex adjustment may overestimate the male-female height difference in certain East Asian populations, where the average difference may be closer to 11 to 12 cm. Conversely, in some Northern European populations, the difference may exceed 13 cm. Population-specific reference data, where available, may provide more accurate predictions for specific ethnic groups. The World Health Organization (WHO) growth standards, based on data from children in Brazil, Ghana, India, Norway, Oman, and the United States, provide a global framework for assessing child growth but do not include specific mid-parental height correction factors.

Healthcare providers should consider ethnic background when interpreting mid-parental height calculations. For populations where local reference data exists, population-specific adjustments may improve accuracy. In multiethnic clinical settings, the standard Tanner formula with a target range of plus or minus 8.5 to 10 cm remains a practical and widely accepted approach, acknowledging that individual variation within any population is substantial.

Alternative Methods for Predicting Adult Height

While the mid-parental height formula provides a quick genetic estimate, several other methods exist for predicting a child’s final adult height, each with distinct advantages and limitations. The bone age method, using the Greulich-Pyle atlas or the Tanner-Whitehouse method, assesses skeletal maturity from a left hand and wrist radiograph. By comparing a child’s bone age to their chronological age and using tables that relate bone age to the percentage of adult height achieved, clinicians can estimate final adult height. This method is particularly valuable when growth plate maturation is advanced or delayed relative to chronological age.

The Bayley-Pinneau method combines bone age assessment with current height to predict adult height using specific tables for average, accelerated, and retarded bone maturation. The Roche-Wainer-Thissen (RWT) method uses a statistical approach incorporating current height, weight, bone age, and mid-parental height to generate a predicted adult height with confidence intervals. The Khamis-Roche method is notable because it does not require bone age radiography, using instead the child’s current height, weight, and mid-parental height to predict adult height.

More recently, artificial intelligence and machine learning approaches have been developed that incorporate multiple variables including genetic data, growth trajectory, bone age, pubertal stage, and environmental factors to generate more personalized height predictions. While promising, these approaches are still primarily in the research phase and are not yet widely available in clinical practice. For most clinical situations, the combination of mid-parental height calculation, growth chart analysis, and bone age assessment when indicated provides a reliable framework for evaluating a child’s growth potential.

Growth Charts and Mid-Parental Height: Using Them Together

Mid-parental height is most informative when used alongside standard growth charts. The two most commonly used growth references worldwide are the CDC 2000 growth charts (widely used in the United States for children aged 2 to 20 years) and the WHO growth standards (recommended for children from birth to 5 years and available for older children as well). Both provide percentile curves that allow clinicians to plot a child’s height relative to age- and sex-specific population norms.

To integrate mid-parental height with growth chart analysis, clinicians typically plot the calculated target height at the 18- to 20-year mark on the growth chart, along with the target height range (MPH plus or minus 8.5 cm). The child’s current growth trajectory is then extrapolated to adult height. If the projected adult height falls within the target range, the child’s growth is considered consistent with genetic potential. If the projected height falls below the target range, the child may be growing below their genetic potential, warranting further evaluation.

Growth velocity, measured as centimeters of height gained per year, provides additional context. A child whose height percentile is declining over time (crossing percentile lines downward) may have an underlying growth problem even if their current height is still within the normal range. Conversely, a child who is consistently short but growing at a normal velocity along a stable percentile is more likely to have familial short stature or constitutional delay of growth and puberty, particularly if their height falls within the parental target range.

Understanding the Target Height Range

The target height range, typically expressed as the mid-parental height plus or minus 8.5 cm, represents the statistically expected range within which approximately 94% of healthy children will achieve their final adult height. This range corresponds to the 3rd through 97th percentiles of expected height based on parental genetics. Some clinical guidelines use a broader range of plus or minus 10 cm (approximately 2 standard deviations), which captures approximately 95% of the expected distribution.

It is important to understand that this range is an approximation. The actual distribution of children’s heights around the mid-parental height follows a roughly normal distribution, meaning most children will be relatively close to the calculated MPH, with progressively fewer children at the extremes of the range. A child whose projected height is just at the edge of the target range should not be automatically classified as having abnormal growth. Clinical judgment, considering the overall growth pattern, pubertal timing, and family history, is essential.

The American Academy of Pediatrics and the Pediatric Endocrine Society recommend that a child whose height deviates more than 2 standard deviations from the mid-parental target height (roughly equivalent to being outside the plus or minus 10 cm range) should be evaluated for potential growth disorders. However, some experts advocate using probability-based approaches rather than rigid cutoffs, recognizing that the probability of a normal child falling at any particular deviation from the target height follows a continuous distribution rather than a binary normal/abnormal classification.

Pubertal Timing and Its Impact on Final Height

The timing of puberty has a significant impact on final adult height and can cause a child’s growth trajectory to deviate temporarily from what the mid-parental height would predict. Children who enter puberty early (precocious puberty) experience their growth spurt sooner but also undergo earlier growth plate fusion, potentially compromising their final adult height. Conversely, children with constitutional delay of growth and puberty enter puberty later than their peers, may appear short during adolescence, but often achieve a normal final adult height consistent with their mid-parental target.

During puberty, the growth spurt typically begins at Tanner stage II to III in girls and Tanner stage III to IV in boys. Girls experience peak height velocity at approximately age 11.5 years (range 10 to 14), gaining about 8 cm per year at peak velocity. Boys experience peak height velocity at approximately age 13.5 years (range 12 to 16), gaining about 9 to 10 cm per year at peak velocity. After menarche in girls, approximately 5 to 7 cm of additional growth remains. After peak height velocity in boys, growth continues for another 2 to 3 years before growth plate fusion.

Constitutional delay of growth and puberty (CDGP) is one of the most common causes of short stature in adolescents and is typically characterized by delayed bone age, a family history of late puberty in one or both parents, and eventual achievement of normal adult height. Children with CDGP often have a height that falls below the mid-parental target range during childhood and adolescence but catch up during their extended growth period. A bone age assessment can be particularly helpful in distinguishing CDGP from pathological causes of short stature.

Common Conditions Affecting Growth

Several medical conditions can cause a child’s growth to deviate significantly from the mid-parental height prediction. Growth hormone deficiency (GHD) affects approximately 1 in 4,000 to 10,000 children and is characterized by slow growth velocity, delayed bone age, and short stature that typically falls below the parental target range. GHD may be congenital or acquired and is diagnosed through growth hormone stimulation testing, with treatment involving daily injections of recombinant human growth hormone.

Turner syndrome, affecting approximately 1 in 2,500 female births, is caused by complete or partial absence of one X chromosome. Girls with Turner syndrome typically have significant short stature, often falling well below the mid-parental target range, along with other features such as broad chest, webbed neck, and ovarian insufficiency. Early diagnosis and treatment with growth hormone can improve final adult height, though most affected individuals will still be shorter than their mid-parental prediction.

Hypothyroidism, whether congenital or acquired, impairs growth through its effects on growth plate function and growth hormone secretion. Celiac disease, an autoimmune condition triggered by gluten ingestion, can cause growth failure through malabsorption of nutrients even in the absence of gastrointestinal symptoms. Chronic inflammatory conditions, including juvenile idiopathic arthritis and inflammatory bowel disease, can impair growth through a combination of chronic inflammation, corticosteroid treatment, and nutritional deficits. In all these conditions, the deviation of the child’s growth from the mid-parental target height is an important diagnostic and monitoring parameter.

Regional Variations and Alternative Calculators

Different regions and healthcare systems have developed various approaches to predicting adult height from parental data. In the United Kingdom, the QRISK-based growth assessment and the UK-WHO growth charts are commonly used alongside mid-parental height calculations. European guidelines from the European Society for Paediatric Endocrinology (ESPE) recommend the standard Tanner formula with population-specific reference data where available.

In some East Asian countries, modified formulas have been developed that use sex adjustment factors of 11 to 12 cm rather than the standard 13 cm, reflecting the slightly smaller average height difference between males and females in these populations. Japanese pediatric guidelines, for example, use a correction factor of 13 cm but provide population-specific target height ranges. Korean and Chinese studies have similarly validated and sometimes modified the formula for local populations.

The Khamis-Roche method, which does not require bone age radiography, has been validated in diverse populations and is particularly useful in resource-limited settings. This method uses the child’s current height, current weight, and mid-parental height to predict adult height, with accuracy improving as the child gets older. For children aged 4 years and older, the Khamis-Roche method provides predictions within approximately 2.2 cm of actual adult height in validation studies. Regardless of the specific method used, the principle of comparing a child’s growth to their parental genetic potential remains a cornerstone of pediatric growth assessment worldwide.

Practical Tips for Parents

Parents often have questions and concerns about their child’s height. Here are some practical considerations for interpreting mid-parental height calculations. First, remember that the calculation provides a range, not a precise prediction. Your child’s final height may fall anywhere within the target range, and some healthy children will even fall slightly outside it. The mid-parental height is best used as a general guide rather than an exact forecast.

Second, ensure that the heights used in the calculation are as accurate as possible. If possible, have both parents measured by a healthcare provider using a stadiometer. If measured heights are not available, be aware that self-reported heights tend to be overestimates, particularly for fathers and for older individuals who may have experienced age-related height loss. Using inflated height values will result in an artificially high target height for the child.

Third, do not compare siblings to each other or expect all children in a family to reach the same height. Due to the polygenic nature of height inheritance, siblings may inherit different combinations of height-related genetic variants from their parents. It is entirely normal for siblings to have different final adult heights, all within the parental target range. Similarly, the birth order, sex, and pubertal timing of each child will influence their growth trajectory and final height.

Finally, focus on what you can control. While you cannot change your child’s genetic potential, you can optimize their environment for growth by ensuring adequate nutrition (particularly protein, calcium, vitamin D, zinc, and iron), promoting regular physical activity and adequate sleep, managing any chronic health conditions promptly, and providing a supportive emotional environment. These factors collectively help ensure that your child reaches their full genetic height potential.

The Role of Bone Age in Growth Assessment

Bone age assessment is a complementary tool that, when combined with mid-parental height, provides a more complete picture of a child’s growth potential. A bone age radiograph (typically a left hand and wrist X-ray) is compared to reference standards (the Greulich-Pyle atlas or Tanner-Whitehouse method) to determine the skeletal maturity of the child. The bone age may be equal to, advanced beyond, or delayed relative to the chronological age.

A delayed bone age (skeletal maturity younger than chronological age) suggests that the child has more remaining growth potential than would be predicted by chronological age alone. This is a common finding in constitutional delay of growth and puberty (CDGP), where children are often short for their age but have a bone age that is 2 or more years delayed, indicating that they will continue growing for a longer period than their peers. In these cases, the eventual adult height often falls within the mid-parental target range despite the child appearing short during childhood.

Conversely, an advanced bone age (skeletal maturity older than chronological age) indicates that growth plates are maturing faster than expected, potentially limiting the remaining growth period. This is commonly seen in precocious puberty, obesity, and some genetic conditions. In these cases, the predicted adult height may be lower than what the mid-parental height would suggest. Bone age assessment is particularly valuable in distinguishing between constitutional delay (delayed bone age) and familial short stature (bone age equal to chronological age), two conditions that require different clinical approaches.

When to Consult a Healthcare Professional

While the mid-parental height calculator is a useful screening tool, certain situations warrant professional medical evaluation. Consider consulting a pediatric endocrinologist or your child’s healthcare provider if your child’s height is below the 3rd percentile for age, if their growth velocity is below normal for age (less than 5 cm per year in prepubertal children after age 4), if they are crossing percentile lines downward on the growth chart, or if their projected adult height falls significantly below the mid-parental target range (more than 10 cm below the calculated MPH).

Other warning signs that may indicate an underlying growth disorder include extreme short stature in a child with parents of average or above-average height, very early or very late onset of puberty (before age 8 in girls or 9 in boys, or no signs of puberty by age 13 in girls or 14 in boys), disproportionate body proportions (such as short limbs relative to trunk length), and associated symptoms such as chronic fatigue, constipation, or cold intolerance that might suggest thyroid dysfunction.

A comprehensive growth evaluation typically includes a detailed medical history and family history, physical examination with accurate height measurement, growth chart review with calculation of growth velocity, bone age assessment, and laboratory studies that may include thyroid function tests, IGF-1 and IGFBP-3 levels, complete blood count, comprehensive metabolic panel, and celiac screening. In some cases, growth hormone stimulation testing, karyotype analysis (especially in girls with unexplained short stature), or genetic testing may be recommended.

Historical Development of Height Prediction Methods

The scientific study of height inheritance has a rich history dating back to the 19th century. Sir Francis Galton, often called the father of quantitative genetics, published his seminal work on hereditary stature in 1886, establishing the concept of regression to the mean and calculating the first parent-child height correlations. His observation that tall parents tend to have children who are shorter than themselves, and short parents tend to have children who are taller, laid the groundwork for modern height prediction methods.

Karl Pearson and Alice Lee extended Galton’s work in 1903 with more sophisticated statistical analyses of height inheritance. In 1970, James Tanner, Herbert Goldstein, and R.H. Whitehouse published their landmark paper proposing the sex-adjusted mid-parental height method that is still used today. Their formula was elegant in its simplicity: average the parents’ heights after adjusting for sex, and use a range of plus or minus 8.5 cm to capture the 3rd to 97th percentiles of expected child height.

Subsequent refinements have been proposed over the decades. In 1975, Roche, Wainer, and Thissen developed a prediction method incorporating multiple variables. In 1994, Khamis and Roche proposed a method that did not require bone age assessment. In 2024, Rennert and colleagues published a comprehensive reanalysis of the Tanner method using large family data, demonstrating improvements in prediction accuracy by correcting for parental age, using a multiplicative rather than additive sex correction, and accounting for regression to the mean. Despite these refinements, the original Tanner formula remains the most widely used method in clinical practice due to its simplicity and reasonable accuracy.

Units and Measurement Considerations for Global Users

This calculator supports both metric (centimeters) and imperial (feet and inches) measurement systems. Different regions use different measurement conventions, so it is important to ensure that you are entering heights in the correct units. The metric system is the standard in most countries worldwide and in medical practice, while feet and inches remain common in everyday use in the United States, the United Kingdom, and several other countries.

Conversion formulas: 1 inch equals 2.54 cm, and 1 foot equals 30.48 cm. For example, a height of 5 feet 10 inches equals 70 inches, which equals 177.8 cm. When converting between systems, round to the nearest 0.5 cm for practical purposes. The calculator handles these conversions automatically when you select your preferred unit system.

For the most accurate height measurements, follow these best practices: measure height at the same time of day (heights are typically 1 to 2 cm taller in the morning due to spinal disc compression throughout the day), remove shoes and heavy headwear, stand with feet together and back straight against a wall or stadiometer, look straight ahead with the Frankfort plane horizontal (the lower border of the eye socket aligned with the upper border of the ear canal), and use a flat headpiece pressed firmly on the crown of the head. In children under 2 years of age, length (measured lying down) rather than height (measured standing) is used, and the two measurements differ by approximately 0.7 cm.

Frequently Asked Questions

Conclusion

The mid-parental height calculator is a valuable, evidence-based tool that provides families and healthcare providers with a quick estimate of a child’s genetic height potential. Based on the time-tested Tanner method, it uses both biological parents’ heights to calculate a target height and expected range for the child’s final adult stature. While no prediction method is perfect, mid-parental height remains a cornerstone of pediatric growth assessment, endorsed by major pediatric endocrine societies worldwide.

Remember that the mid-parental height calculation provides a range of expected heights, not a single precise prediction. Most healthy children will achieve an adult height within this range, but individual variation is normal. Environmental factors including nutrition, sleep, physical activity, emotional wellbeing, and the management of any chronic health conditions all play a role in determining whether a child reaches their full genetic potential. If you have concerns about your child’s growth, use this calculator as a starting point for discussion with your healthcare provider, who can provide personalized assessment and guidance.